# Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand

> **NCT01130961** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 104 (actual)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01130961
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2010-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130961, "Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT01130961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*